Greenwich LifeSciences In... (GLSI)

AI Score

Unlock

8.95

0.11 (1.24%)

At close: Apr 17, 2025, 3:59 PM

8.75

-2.23%

After-hours: Apr 17, 2025, 07:41 PM EDT

Greenwich LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-8.04M	-2.67M	-2.61M	-2.47M	-2.75M	-2.39M	-1.63M	-2.12M	-2.79M	-2.32M	-746.07K	-1.97M	-2.36M	-863.12K	-749.75K	-597.01K	-1.15M	-256.87K	-210.43K	-244.64K	-336.54K	-336.01K	-2.6M	-148.73K
Depreciation & Amortization	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	903.00	901.00	902.00	902.00	902.00	901.00	902.00
Stock-Based Compensation	5.47M	594.52K	594.52K	594.52K	594.52K	594.52K	594.52K	594.52K	594.52K	759.57K	224.5K	165.27K	165.43K	165.05K	165.05K	165.05K	165.05K	165.05K	173.94K	173.94K	194.94K	n/a	n/a	n/a
Other Working Capital	-950.75K	49.83K	-25.23K	4.94K	-28.3K	65.3K	65.97K	-27.33K	25.03K	8.74K	-12.03K	-144K	5.05K	134.26K	-20.53K	22.78K	-60.34K	75.91K	35.59K	69.8K	-143.78K	135.81K	2.6M	-47.46K
Other Non-Cash Items	1.27M	n/a	n/a	506.06K	570.91K	596.33K	596.33K	596.33K	596.33K	761.38K	226.31K	167.07K	2.21M	498.59K	166.86K	286.86K	362.25K	15K	0.00	0.00	-2	200.2K	7.6K	115.29K
Deferred Income Tax	n/a	n/a	n/a	n/a	-570.91K	-596.33K	-596.33K	-596.33K	-596.33K	-761.38K	-226.31K	n/a	-2.21M	n/a	n/a	n/a	-362.25K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-547.98K	-510.64K	963.42K	95.2K	-2.88K	-4.26K	65.97K	-27.33K	25.03K	8.74K	-12.03K	-144K	-69.95K	-197.47K	-20.53K	-97.22K	-167.89K	90.91K	35.59K	69.8K	-73.47K	336.01K	2.6M	-47.46K
Operating Cash Flow	-1.85M	-2.58M	-1.05M	-1.78M	-2.15M	-1.8M	-966.98K	-1.56M	-2.17M	-1.55M	-532.7K	-1.95M	-2.26M	-894.64K	-604.32K	-528.27K	-1.15M	n/a	n/a	n/a	-214.17K	900.00	n/a	-80K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-7.54M	n/a	-2.02M	-5.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.19M	1.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-275.15K	-360K	n/a	n/a	n/a	215K	n/a	n/a	n/a
Financial Cash Flow	121.83K	1.18M	2.77M	299.12K	n/a	n/a	n/a	n/a	-7.54M	n/a	-2.02M	-5.51M	562.6K	n/a	n/a	2.27M	23.6M	6.21M	n/a	n/a	215K	n/a	n/a	n/a
Net Cash Flow	-1.73M	-1.4M	1.72M	-1.48M	-2.15M	-1.8M	-966.98K	-1.56M	-2.17M	-1.55M	-2.56M	-7.46M	-1.7M	-894.64K	-604.32K	1.74M	22.45M	6.21M	n/a	n/a	833.00	900.00	n/a	-80K
Free Cash Flow	-1.85M	-2.58M	-1.05M	-1.78M	-2.15M	-1.8M	-966.98K	-1.56M	-2.17M	-1.55M	-532.7K	-1.95M	-2.26M	-894.64K	-604.32K	-528.27K	-1.15M	n/a	n/a	n/a	-214.17K	900.00	n/a	-80K